ロクロニウム (Japanese Wikipedia)

Analysis of information sources in references of the Wikipedia article "ロクロニウム" in Japanese language version.

refsWebsite

Global rank Japanese rank

4^th place

24^th place

2^nd place

6^th place

6,690^th place

394^th place

low place

low place

304^th place

20^th place

1anesthesia-analgesia.org

low place

low place

1web.archive.org

1^st place

1^st place

1pharmatimes.com

low place

low place

447^th place

1,043^rd place

anesthesia-analgesia.org

Naguib M (March 2007). “Sugammadex: another milestone in clinical neuromuscular pharmacology”. Anesthesia and Analgesia 104 (3): 575–81. doi:10.1213/01.ane.0000244594.63318.fc. PMID 17312211.

doi.org

Hunter JM (April 1996). “Rocuronium: the newest aminosteroid neuromuscular blocking drug”. British Journal of Anaesthesia 76 (4): 481–3. doi:10.1093/bja/76.4.481. PMID 8652315.
Naguib M (March 2007). “Sugammadex: another milestone in clinical neuromuscular pharmacology”. Anesthesia and Analgesia 104 (3): 575–81. doi:10.1213/01.ane.0000244594.63318.fc. PMID 17312211.
Carron, Michele; Zarantonello, Francesco; Tellaroli, Paola; Ori, Carlo (2016). “Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials”. Journal of Clinical Anesthesia 35: 1–12. doi:10.1016/j.jclinane.2016.06.018. PMID 27871504.

fda.gov

“Press Announcements - FDA approves Bridion to reverse effects of neuromuscular blocking drugs used during surgery” (英語). www.fda.gov. 2017年1月7日閲覧。

nih.gov

pubmed.ncbi.nlm.nih.gov

Hunter JM (April 1996). “Rocuronium: the newest aminosteroid neuromuscular blocking drug”. British Journal of Anaesthesia 76 (4): 481–3. doi:10.1093/bja/76.4.481. PMID 8652315.
“Anaesthetic management in asthma”. Minerva Anestesiologica 73 (6): 357–65. (June 2007). PMID 17115010.
Naguib M (March 2007). “Sugammadex: another milestone in clinical neuromuscular pharmacology”. Anesthesia and Analgesia 104 (3): 575–81. doi:10.1213/01.ane.0000244594.63318.fc. PMID 17312211.
Carron, Michele; Zarantonello, Francesco; Tellaroli, Paola; Ori, Carlo (2016). “Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials”. Journal of Clinical Anesthesia 35: 1–12. doi:10.1016/j.jclinane.2016.06.018. PMID 27871504.

nii.ac.jp

cir.nii.ac.jp

伊藤, 博徳「非脱分極性筋弛緩薬による神経筋遮断と四連反応比の関係」『金沢大学十全医学会雑誌』第105巻第1号、1996年2月1日、154–161頁。

pharmatimes.com

McKee, Selina (September 24, 2013). “FDA turns down Merck & Co's sugammadex again”. PharmaTimes. February 22, 2014時点のオリジナルよりアーカイブ。2021年11月10日閲覧。

pmda.go.jp

info.pmda.go.jp

“エスラックス静注25mg/2.5ｍL、50mg/5.0ｍL”. 2017年3月5日閲覧。
“エスラックス静注25mg/2.5mL／エスラックス静注50mg/5.0mL 添付文書”. www.info.pmda.go.jp. 2021年11月10日閲覧。

selleck.co.jp

“Rocuronium Bromide | ≥99%(HPLC) | Selleck | AChR 拮抗剤”. www.selleck.co.jp. 2023年12月15日閲覧。

web.archive.org

McKee, Selina (September 24, 2013). “FDA turns down Merck & Co's sugammadex again”. PharmaTimes. February 22, 2014時点のオリジナルよりアーカイブ。2021年11月10日閲覧。